Vanda Pharmaceuticals' (VNDA) MAA for Fanaptum in Schizophrenia Accepted for Evaluation by EMA
Go back to Vanda Pharmaceuticals' (VNDA) MAA for Fanaptum in Schizophrenia Accepted for Evaluation by EMA| Vanda Pharmaceuticals, Inc. (NASDAQ: VNDA) | Delayed: 4.56 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.56 | 52 Week High | $18.00 | |||
| Open | $4.56 | 52 Week Low | $6.91 | |||
| Day High | $4.56 | P/E | N/A | |||
| Day Low | $4.56 | EPS | $-0.67 | |||
| Volume | 12,489 | |||||
